1. Home
  2. RAMP vs STOK Comparison

RAMP vs STOK Comparison

Compare RAMP & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LiveRamp Holdings Inc.

RAMP

LiveRamp Holdings Inc.

HOLD

Current Price

$29.08

Market Cap

1.7B

Sector

Technology

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$33.49

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAMP
STOK
Founded
2018
2014
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
RAMP
STOK
Price
$29.08
$33.49
Analyst Decision
Buy
Strong Buy
Analyst Count
5
10
Target Price
$35.60
$39.20
AVG Volume (30 Days)
533.0K
648.1K
Earning Date
05-20-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
92.73
EPS
1.14
N/A
Revenue
$745,580,000.00
$184,420,000.00
Revenue This Year
$11.18
N/A
Revenue Next Year
$9.09
$77.49
P/E Ratio
$24.60
N/A
Revenue Growth
13.02
404.50
52 Week Low
$21.71
$8.30
52 Week High
$35.20
$40.22

Technical Indicators

Market Signals
Indicator
RAMP
STOK
Relative Strength Index (RSI) 59.38 45.21
Support Level $25.30 $32.70
Resistance Level $30.80 $35.06
Average True Range (ATR) 1.01 1.60
MACD 0.22 -0.06
Stochastic Oscillator 75.78 31.16

Price Performance

Historical Comparison
RAMP
STOK

About RAMP LiveRamp Holdings Inc.

LiveRamp Holdings Inc is a technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics, and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust. The Company provides a data collaboration platform, essentially acting as a data collaboration hub where businesses can securely share and manage first-party consumer data with trusted partners while prioritizing data privacy and ethics.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: